Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study
Jose D. Herazo‐Maya(University of South Florida), Naftali Kaminski(Yale University), Imre Noth(University of Virginia), Julian A. Villalba(Centers for Disease Control and Prevention), Melinda Klesen(University of Pittsburgh), Argyrios Tzouvelekis(University of Patras), Erica L. Herzog(Yale University), Antje Prasse(University Medical Center Freiburg), George Michel(Yale University), Kathleen O. Lindell(Medical University of South Carolina), Iván O. Rosas(Brigham and Women's Hospital), Heather Lynn(Yale University), Brenda Juan-Guardela(Yale University), Joe G. N. Garcia(Scripps Research Institute), Nachelle Aurelien(Yale University), Miriam F. Moffatt(Lung Institute), Kevin F. Gibson(University of Pittsburgh), Toby M. Maher(University of Southern California), Philip L. Molyneaux(Guy's and St Thomas' NHS Foundation Trust), Ziv Bar‐Joseph(Carnegie Mellon University), Juan C. Osorio(Laboratory of Molecular Genetics), Hongyu Zhao(Yale University), Cristobal Risquez(Cornell University), Xiting Yan(Yale University), Qin Li(Yale University), William Cookson(Lung Institute), Yingze Zhang(Hebei Medical University), Jiehuan Sun(Yale University)
Cited by 191
Related Papers
Sarcoidosis
|The Lancet|2013|1.1k
Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands
|Nature Genetics|2017|930
Plasticity of marrow-derived stem cells
|Blood|2003|830